Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

AstraZeneca's treatment for adults with muscle-invasive bladder cancer was approved in the U.S.

ABOUT 55,000 new prostate cancer cases are recorded every year in the UK. Bladder cancer is less common, with around 10,500 ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

【导读】虽然厄达替尼在膀胱癌治疗中展现了良好的效果，但其耐药性的问题不容忽视。近日，华中科技大学的研究团队在《Advanced Science》期刊上发布了重要研究，题为“Targeting COPA to Enhance Erdafitinib Sensitivity in FGFR-Altered Bladder ...

Eddie Jordan, the Formula 1 legend, died on Thursday in Cape Town, South Africa following a journey with bladder cancer, ...

The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in ...

AstraZeneca’s Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Survey suggests bladder cancer incidence around five times higher for veterans under 70 compared to the general public ...

Bladder cancer spreads at different speeds depending on the type of bladder cancer you have. Urothelial bladder cancer is slow to spread, while other types are much faster. Urothelial bladder ...

Symptoms of prostate cancer may include needing to urinate more frequently; having to rush to the toilet; straining to ...